OncoResponse

oncoresponseinc.com

OncoResponse is an immuno-oncology biotech company focused on discovering novel cancer immunotherapies by leveraging elite immune responses. The company utilizes a clinically validated technology platform to develop authentic human antibodies targeting immunosuppressive myeloid biology. Their pipeline includes monoclonal antibodies designed to relieve immunosuppression in the tumor microenvironment (TME) and enhance immune activity, effectively transforming 'cold' tumors into 'hot' ones. With a strong emphasis on collaboration and strategic partnerships, OncoResponse is positioned to make significant advancements in the field of immunotherapy.